HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Overview Fund Activity
Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

24 hedge funds and large institutions have $16.4M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
3
Increased
10
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$3.56M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.41M
3
SC
3
Samjo Capital
New York
$3.1M
4
WVP
4
Worth Venture Partners
New Jersey
$832K
5
CPA
5
Cowen Prime Advisors
New York
$3.31M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$332K
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
Squarepoint
3
Squarepoint
New York
$71K
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
5
BWLSA
5
Blue Water Life Science Advisors
California
$841K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
27
Wells Fargo
California
$0 37 +9 +32%
UBS Group
28
UBS Group
Switzerland
$0 59 +33 +127%
1
2